Acamprosate Inhibits the Binding and Neurotoxic Effects of Trans‐ACPD, Suggesting a Novel Site of Action at Metabotropic Glutamate Receptors
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background Several reported effects of acamprosate within the glutamatergic system could result from interactions with metabotropic glutamate receptors (mGluRs). The following experiments were performed to determine whether acamprosate could compete with trans‐ACPD (±‐1‐aminocyclopentane‐trans‐1,3‐dicarboxylic acid, an equimolecular mixture of 1 S, 3 R and 1 R, 3 S‐ACPD and an agonist at both group I and group II mGluRs) sensitive binding sites and protect against trans‐ACPD–induced neurotoxicity in organotypic hippocampal slice cultures. Methods A P2 membrane preparation of cortices, cerebellums, and hippocampi of adult, male Sprague Dawley rats was used to determine the abilities of N‐methyl‐d‐aspartic acid (NMDA) and trans‐ACPD to displace [3 H]glutamate in both the absence and the presence of the sodium salt of acamprosate (sodium mono N‐acetyl homotaurine or Na‐acamprosate). A comparison of the effects of 100 μM guanosine 5′‐triphosphate on unlabeled glutamate, trans‐ACPD, and Na‐acamprosate was performed in the same paradigm. For the neurotoxicity studies, organotypic hippocampal slice cultures from male and female 8‐day‐old neonatal rats were exposed to either 500 μM trans‐ACPD or 50 μM NMDA for 24 hr in normal culture medium containing serum on day 20 in vitro. The effects of Na‐acamprosate and 2‐methyl‐6‐(2‐phenylethenyl)pyridine (SIB‐1893), a noncompetitive antagonist at metabotropic type 5 receptors (mGluR5s), were assessed by determining differences in propidium iodide uptake as compared with neurotoxic challenges alone. Results Na‐acamprosate displaced 31% of [3 H]glutamate but did not compete with NMDA for [3 H]glutamate binding sites. Na‐acamprosate displayed total competition with trans‐ACPD. The presence of 100 μM guanosine 5′‐triphosphate differentially altered the displacing capabilities of the two mGluR agonists, unlabeled glutamate and trans‐ACPD, as compared with Na‐acamprosate. Na‐acamprosate (200–1000 μM) and SIB‐1893 (20–500 μM) both were neuroprotective against trans‐ACPD induced neurotoxicity that likely results from mGluR potentiation of NMDARs. In turn, Na‐acamprosate and SIB‐1893 had no direct effects on NMDA‐induced neurotoxicity. Conclusions Na‐acamprosate demonstrates the binding and functional characteristics that are consistent with a group I mGluR antagonist. The functional similarities between Na‐acamprosate and SIB‐1893 support an interaction of Na‐acamprosate at mGluR5s. The neuroprotective properties of acamprosate and possibly its ability to reduce craving in alcohol‐dependent patients may result from its alterations in glutamatergic transmission through mGluRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
Cartmell, J., & Schoepp, D. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750889.x · Cited by 883
Dahchour, A., De Witte, P., Bolo, N., Nédélec, J.-F., Muzet, M., Durbin, P., & Macher, J.-P. (1998) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(98)00016-x · Cited by 165
Blaabjerg, M., Kristensen, B. W., Bonde, C., & Zimmer, J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02148-5 · Cited by 29
Cited by
Glutamatergic substrates of drug addiction and alcoholism
Gass, J. T., & Olive, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.039 · Cited by 484
Mann, K., Lehert, P., & Morgan, M. Y. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000108656.81563.05 · Cited by 364
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 264
Glutamatergic medications for the treatment of drug and behavioral addictions
Olive, M. F., Cleva, R. M., Kalivas, P. W., & Malcolm, R. J. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.015 · Cited by 210
“…confirmed an interaction of acamprosate with the spermidine-, glutamate- and/or MK-801-sensitive binding site of the NMDA receptor (al Qatari et al., 1998; Harris et al., 2002; Naassila et al., 1998), and as such acamprosate is often referred to nonspecifically as an “NMDA modulator” (Figure 1).”
BackgroundNeuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action
De Witte, P., Littleton, J., Parot, P., & Koob, G. (2005) · CNS Drugs · doi:10.2165/00023210-200519060-00004 · Cited by 201
Self-citation
Metadata
- Authors
- Harris, B. R., Prendergast, M. A., Gibson, D. A., Rogers, D. T., Blanchard, J. A., Holley, R. C., Fu, M. C., Hart, S. R., Pedigo, N. W., & Littleton, J. M.
- Venue
- Alcoholism: Clinical and Experimental Research
- Publisher
- Wiley
- Published
- 2002-12
- Volume
- 26
- Issue
- 12
- Pages
- 1779-1793
- ISSN
- 0145-6008 (ISSN-L)
- 1530-0277
- OpenAlex
- W4230396476
- Cited by
- 110
- References
- 3
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.